Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
11030672 | Atherosclerosis | 2018 | 7 Pages |
Abstract
HoFH due to LDLR mutations is a severe disorder in Vietnam that needs early detection and treatment with LDL-cholesterol lowering drugs. Cascade testing of families allows effective detection of new cases of FH that may also benefit from early treatment. However, convincing patients to commence statin treatment is a challenge. Extended education and awareness programs and treatment subsidies are imperative to improve the care of patients and families suffering from FH in Vietnam.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Thanh Huong Truong, Ngoc Thanh Kim, Mai Ngoc Thi Nguyen, Jing Pang, Amanda J. Hooper, Gerald F. Watts, Doan Loi Do,